ADOGEL® SEMA

索马鲁肽长效注射剂 (Adocia)

Report date: 2023/12/15 09:14:59
NME

Base Information

Drug NameADOGEL® SEMA
Drug Alias NameSemaglutide long-acting injectable (Adocia)司美格鲁肽长效注射剂 (Adocia)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdocia
China Registration ClassN/A

Develop Information

Active CompaniesAdocia
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A